Abstract
Reaction of PdCl2 with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol (Hmtzt) in the presence of 5,5′-dimethyl-2,2′-bipyridine (5,5′-dmbipy) and 4,4′-dimethyl-2,2′-bipyridine ligands (4,4′-dmbipy) afforded two new Pd(II) complexes, [Pd(5,5′-dmbipy)(mtzt)2] (1) and [Pd(4,4′-dmbipy)(mtzt)2] (2), respectively. The two complexes were thoroughly characterized by elemental analysis, UV-vis, 1H NMR, IR, luminescence spectroscopy as well as single-crystal X-ray diffraction. Single-crystal X-ray diffraction revealed that central Pd(II) ions in 1 and 2 are tetra-coordinated, presenting distorted and slightly distorted square planar geometry around Pd atom for 1 and 2, respectively. The luminescence properties of free ligands and complexes 1 and 2, in solution, were investigated. The biological evaluation of the Pd(II) complexes showed that they exhibited anticancer activities in a dose-dependent manner against human breast cancer cell lines. Also, their in vitro interaction with DNA were analyzed through spectrophotometric, spectrofluorometric, and gel-electrophoresis which shows the intercalation mode of binding. In conclusion, these palladium complexes represent novel anticancer drug molecules for further study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
